Literature DB >> 30213477

Fetal-placental crosstalk occurs through fetal cytokine synthesis and placental clearance.

Imran N Mir1, Lina F Chalak2, Jie Liao2, Sarah Johnson-Welch3, Larry S Brown4, Christopher Longoria2, Rashmin C Savani5, Charles R Rosenfeld2.   

Abstract

BACKGROUND: Cytokines modulate fetal well-being and contribute to parturition. Their origin in fetal blood, whether maternal, placental or fetal, at the time of parturition remains unclear.
OBJECTIVE: To determine fetal and placental contributions to circulating fetal cytokines by measuring umbilical arterial (UmA) and venous (UmV) concentration differences in uncomplicated term pregnancies in the absence and presence of labor.
METHODS: Term uncomplicated pregnancies were assessed: Group 1 were not in labor and delivered by elective cesarean section (n = 20); Group 2 delivered vaginally following uncomplicated pregnancy and labor (n = 30). UmA and UmV blood was collected before delivery of the placenta to measure circulating cytokines. Placental tissue was collected for histology and to determine cytokine contents and localization.
RESULTS: Group 1 UmA and UmV IL-10 concentrations were similar (504 ± 15 and 468 ± 16 pg/ml, respectively; P ≥ 0.1); other cytokines were below level of detection. During labor, IL-10 concentrations increased 15-34%, but placental contents decreased. Group 2 UmA IL-6 and IL-8 concentrations increased (P < 0.001) to 16.7 ± 1.6 and 18.4 ± 4.3 pg/ml, respectively, but were less (P < 0.001) in UmV, 0.29 ± 0.2 and 0.74 ± 0.3 pg/ml, respectively, demonstrating placental clearances ≥97%. This was associated with >6-fold increases in placental IL-6/IL-8 contents (P < 0.001) and chorioamniotic infiltration of activated maternal neutrophils. IL-6 and IL-10 were localized to villous syncytiotrophoblasts.
CONCLUSIONS: In uncomplicated term pregnancies fetal circulating IL-10 is likely of placental origin, whereas IL-6/IL-8 are derived from the fetus, increase during parturition, and circulating levels are modulated by non-saturable placental clearance, revealing a novel pathway for fetal-placental crosstalk and signaling. Published by Elsevier Ltd.

Entities:  

Keywords:  Chorioamnionitis; IL-10; IL-6; IL-8; Maternal neutrophils; Parturition

Mesh:

Substances:

Year:  2018        PMID: 30213477     DOI: 10.1016/j.placenta.2018.07.006

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  4 in total

1.  Placental clearance not synthesis tempers exaggerated pro-inflammatory cytokine response in neonates exposed to chorioamnionitis.

Authors:  Imran N Mir; Naseem Uddin; Jie Liao; Larry S Brown; Rachel Leon; Lina F Chalak; Rashmin C Savani; Charles R Rosenfeld
Journal:  Pediatr Res       Date:  2022-06-11       Impact factor: 3.756

2.  Cytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes.

Authors:  Carlota Dobaño; Azucena Bardají; Myriam Arévalo-Herrera; Flor E Martínez-Espinosa; Camila Bôtto-Menezes; Norma Padilla; Michela Menegon; Swati Kochar; Sanjay Kumar Kochar; Holger Unger; Maria Ome-Kaius; Anna Rosanas-Urgell; Adriana Malheiros; Maria Eugenia Castellanos; Dhiraj Hans; Meghna Desai; Aina Casellas; Chetan E Chitnis; Carlo Severini; Ivo Mueller; Stephen Rogerson; Clara Menéndez; Pilar Requena
Journal:  PLoS Negl Trop Dis       Date:  2020-05-04

3.  Influence of a Concurrent Exercise Training Intervention during Pregnancy on Maternal and Arterial and Venous Cord Serum Cytokines: The GESTAFIT Project.

Authors:  Pedro Acosta-Manzano; Irene Coll-Risco; Mireille N M Van Poppel; Víctor Segura-Jiménez; Pedro Femia; Lidia Romero-Gallardo; Milkana Borges-Cosic; Javier Díaz-Castro; Jorge Moreno-Fernández; Julio J Ochoa-Herrera; Virginia A Aparicio
Journal:  J Clin Med       Date:  2019-11-03       Impact factor: 4.241

4.  Placental pathologic lesions associated with stroke in term neonates.

Authors:  Rachel L Leon; Vinay Kalvacherla; Michelle Machie Andrews; Jennifer M Thomas; Imran N Mir; Lina F Chalak
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.